W
MDCO

Wealthfront’s Medicines Co MDCO Stock Holding History

Wealthfront’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-468
Closed -$18K – 1210
2015
Q3 		$18K Buy
468
+321
+218% +$11.3K ﹤0.01% 795
2015
Q2 		$4K Buy
147
+123
+513% +$3.43K ﹤0.01% 1112
2015
Q1 		$1K Buy
24
+23
+2,300% +$646 ﹤0.01% 1161
2014
Q4 		$0 Buy
+1
New +$25 ﹤0.01% 1084

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthfront's MDCO Position: Q4 2015 in Review

Wealthfront sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 468 shares — an estimated $18K sold.

Wealthfront first reported a position in MDCO in Q4 2014 and held it in 4 quarters. The position peaked at $18K in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • Wealthfront reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 468 Medicines Co shares in Q4 2015, an estimated $18K.
  • Wealthfront first reported a position in Medicines Co in Q4 2014 and held it in 4 quarters.
  • Wealthfront's Medicines Co position peaked at $18K in Q3 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.